SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001370053-23-000033
Filing Date
2023-04-27
Accepted
2023-04-27 16:05:36
Documents
8
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxystatementfy2022_def14a.htm DEF 14A 553001
2 PROXY CARD anaptybiopcv-3_001a.jpg GRAPHIC 181610
3 PROXY CARD anaptybiopcv-3_002a.jpg GRAPHIC 118127
4 COMPENSATION GRAPH compensation_graphx1a.jpg GRAPHIC 113878
5 COMPENSATION GRAPH compensation_graphx2a.jpg GRAPHIC 120238
6 DFSIGNATURE dfsignaturea.jpg GRAPHIC 4102
7 LOGO image_0a.jpg GRAPHIC 13951
8 JTSIGNATURE jtsignature1a02a.jpg GRAPHIC 58580
  Complete submission text file 0001370053-23-000033.txt   1389876
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37985 | Film No.: 23856777
SIC: 2834 Pharmaceutical Preparations